Enacted by Chapter 87, 2014 General Session2014Guidelines for administration of the program. However, chronic administration of ENTOCORT EC.RTM. In one embodiment, the antibodies described herein are human monoclonal antibodies. Anti-cancer immunogenic peptides also include anti-idiotypic “vaccines” such as BEC2 anti-idiotypic antibodies, Mitumomab, CeaVac and related anti-idiotypic antibodies, anti-idiotypic antibody to MG7 antibody, and other anti-cancer […]
Leer más